Takeda Pharmaceutical Company Limited approved the appointment of John Maraganore as External Director, effective from June 29, 2022, Koji Hatsukawa as Head of Audit and Supervisory Committee, Yoshiaki Fujimori as Audit and Supervisory Committee Member, Emiko Higashi as Audit and Supervisory Committee Member, Kimberly A. Reed as External Director, Audit and Supervisory Committee Member, Michel Orsinger as Compensation committee Member, Masami Iijima, Chairperson of Nomination committee and Yoshiaki Fujimori as Nomination committee, effective from June 29, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,069 JPY | -0.49% | -1.86% | +0.37% |
Apr. 19 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
Apr. 19 | Takeda Pharmaceutical Receives FDA Approval for Single-Dose Injection Crohn's Disease Treatment | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.37% | 41.5B | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical Company Limited Announces New Assignments of Directors